218 related articles for article (PubMed ID: 28453745)
1. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Shahar T; Rozovski U; Hess KR; Hossain A; Gumin J; Gao F; Fuller GN; Goodman L; Sulman EP; Lang FF
Neuro Oncol; 2017 May; 19(5):660-668. PubMed ID: 28453745
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
Hossain A; Gumin J; Gao F; Figueroa J; Shinojima N; Takezaki T; Priebe W; Villarreal D; Kang SG; Joyce C; Sulman E; Wang Q; Marini FC; Andreeff M; Colman H; Lang FF
Stem Cells; 2015 Aug; 33(8):2400-15. PubMed ID: 25966666
[TBL] [Abstract][Full Text] [Related]
3. Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years.
Youland RS; Schomas DA; Brown PD; Nwachukwu C; Buckner JC; Giannini C; Parney IF; Laack NN
Neuro Oncol; 2013 Aug; 15(8):1102-10. PubMed ID: 23814262
[TBL] [Abstract][Full Text] [Related]
4. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
[TBL] [Abstract][Full Text] [Related]
5. Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.
Brown CE; Warden CD; Starr R; Deng X; Badie B; Yuan YC; Forman SJ; Barish ME
PLoS One; 2013; 8(10):e77769. PubMed ID: 24204956
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
7. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
[TBL] [Abstract][Full Text] [Related]
8. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
9. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
10. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
Kurogi R; Nakamizo A; Suzuki SO; Mizoguchi M; Yoshimoto K; Amano T; Amemiya T; Takagishi S; Iihara K
J Neurosurg; 2018 Mar; 130(1):44-55. PubMed ID: 29521593
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases.
Marsh JC; Goldman S; Ziel E; Bregman C; Diaz A; Byrne R; Fangusaro J
J Neurooncol; 2015 Mar; 122(1):105-10. PubMed ID: 25502962
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.
Zeng J; Zhang XK; Chen HD; Zhong ZH; Wu QL; Lin SX
Oncotarget; 2016 Feb; 7(8):8944-55. PubMed ID: 26771840
[TBL] [Abstract][Full Text] [Related]
14. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.
Pallud J; Blonski M; Mandonnet E; Audureau E; Fontaine D; Sanai N; Bauchet L; Peruzzi P; Frénay M; Colin P; Guillevin R; Bernier V; Baron MH; Guyotat J; Duffau H; Taillandier L; Capelle L
Neuro Oncol; 2013 May; 15(5):595-606. PubMed ID: 23393207
[TBL] [Abstract][Full Text] [Related]
15. Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort.
Scholtyssek F; Zwiener I; Schlamann A; Seidel C; Meixensberger J; Bauer M; Hoffmann KT; Combs SE; von Bueren AO; Kortmann RD; Müller K
Radiat Oncol; 2013 Jul; 8():161. PubMed ID: 23822643
[TBL] [Abstract][Full Text] [Related]
16. Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.
Kanner AA; Wong ET; Villano JL; Ram Z;
Semin Oncol; 2014 Oct; 41 Suppl 6():S25-34. PubMed ID: 25213871
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma.
Balyasnikova IV; Ferguson SD; Sengupta S; Han Y; Lesniak MS
PLoS One; 2010 Mar; 5(3):e9750. PubMed ID: 20305783
[TBL] [Abstract][Full Text] [Related]
18. Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens.
Kim YG; Jeon S; Sin GY; Shim JK; Kim BK; Shin HJ; Lee JH; Huh YM; Lee SJ; Kim EH; Park EK; Kim SH; Chang JH; Kim DS; Kim SH; Hong YK; Kang SG; Lang FF
Childs Nerv Syst; 2013 Apr; 29(4):549-63. PubMed ID: 23274635
[TBL] [Abstract][Full Text] [Related]
19. CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression.
Zhang Q; Yi DY; Xue BZ; Wen WW; Lu YP; Abdelmaksou A; Sun MX; Yuan DT; Zhao HY; Xiong NX; Xiang W; Fu P
Cell Death Dis; 2018 Oct; 9(11):1101. PubMed ID: 30368520
[TBL] [Abstract][Full Text] [Related]
20. Transcortical insular glioma resection: clinical outcome and predictors.
Hameed NUF; Qiu T; Zhuang D; Lu J; Yu Z; Wu S; Wu B; Zhu F; Song Y; Chen H; Wu J
J Neurosurg; 2018 Oct; 131(3):706-716. PubMed ID: 30485243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
